Site-Selective DNA Binding Drugs  by Ebbinghaus, Scot W.
Chemistry & Biology, Vol. 10, 895–900, October, 2003, 2003 Elsevier Science Ltd. All rights reserved. DOI 10.1016/j .chembiol .2003.10.004
Previews
Furthermore, to date, site-specific mutagenesis had beenSite-Selective DNA Binding Drugs
reported to occur only at low frequency. Importantly, in
addition to providing supporting evidence for the princi-
ple of designing site-specific DNA binding agents, stud-
Last month in Chemistry & Biology, Gottesfeld and ies of triplex-forming oligonucleotides necessitated gener-
colleagues demonstrated that designer DNA binding ation of several molecular methods to detect DNA-bound
drugs could inhibit the expression of target genes in compounds at a single target site in the endogenous
cultured human cells. This landmark observation pro- chromatin of treated cells [9, 12, 16, 17]. While investiga-
vides proof-of-concept for the artificial control of gene tion of antigene triplex-forming oligonucleotides contin-
expression in living cells. ues in several laboratories [12, 18, 19], many investiga-
tors have turned their attention to other approaches to
At the nexus of chemistry and biology, one area that has site-selective DNA recognition to circumvent some of
immense potential impact for the treatment of human the unfavorable side effects, particularly inefficient cel-
disease is the development of DNA binding drugs that lular transport and trafficking, of synthetic nucleic acids
attach to specific target sequences to regulate gene as developmental therapeutic agents and biological tools.
expression. The first synthetic agents capable of selec- Alternative tools employed to target specific regions
tively recognizing double-stranded DNA took the form of double-stranded DNA include designer peptide DNA
of two linked DNA intercalators, such as methidium, that binding domains, usually built from a combination of
bound cooperatively and caused an increase in the length zinc finger peptide subunits selected by phage display,
of the bound nucleotide sequence by stretching [1]. In to create artificial transcription factors and other useful
the 1980s, the “rediscovery” of triplex DNA, initially ob- molecules [20, 21] and cytotoxic DNA interactive small
served in synthetic polynucleotides in 1957 [2], arose molecules, which have been made more potent by link-
from a search for constrained DNA cleavage agents that ing combinations of minor groove binding pharmaco-
cut only certain restricted sites [3, 4]. The identification phores, yielding such compounds as pyrrolo[1,4]ben-
and characterization of such tightly regulated compounds zodiazepine (PBD) dimers [22], bis-benzimidazole dimers
sparked the idea that compounds could be designed to [23], and cyclopropabenzindole (CBI)-PBD combinations
recognize a single DNA target site in the context of [24] with recognition sequences of 6–9 base pairs.
megabase [5] and gigabase [6] eukaryotic genomes. In The promising new strategy of synthetic polyamide
the ensuing decade, a number of groups put forth a large DNA binding agents arose from the examination of DNA
body of work that explored the chemical and biological binding by natural products such as netropsin and dista-
properties of synthetic triplex-forming oligonucleotides mycin, composed of 2 or 3 methylpyrrole groups (Py)
in the “antigene” application of triplex DNA [7]. Their re- coupled by peptide bonds and with selectivity for DNA
search established a number of critical parameters that tracts rich in adenine-thymine (AT) base pairs. This ob-
have since become touchstones for current research: servation inspired the concept of using the Py subunit
double-stranded DNA can be targeted with exquisite as a building block to recognize the AT base pair in
specificity, with good binding affinity in most cases, synthetic minor groove DNA binding agents. Replacing
targeting can take place under physiological conditions, a pyrrole with an imidazole (Im) ring allowed for the
targeting with an oligonucleotide can direct a variety of recognition of guanine-cytosine (GC) base pairs by syn-
nonspecific DNA active agents to specific locations, the thetic polyamides. The discovery of a 5 base pair recog-
triple helix is a substrate for DNA enzymes (e.g., heli- nition sequence and 2:1 polyamide:DNA stoichiometry
case, DNA repair), and triplex formation can mediate in a short ImPyPy trimer led to the deduction of Py and
important biological functions such as inhibition of tar- Im subunit pairing rules for recognition of base pairs
get gene expression and site-directed mutagenesis in in the minor groove [1]. Incremental improvements in
cell-free systems, cells, and whole organisms in some synthetic polyamides have included linking the two poly-
cases [8]. amide chains chemically in a hairpin dimer with an ali-
Despite these successes, cell culture experiments phatic amino acid (abbreviated ; maintains pairing
with triplex-forming oligonucleotides have been difficult alignment and prevents slipped dimers), the substitution
to interpret because of the pleiotropic effects of using of the Py or Im rings with -alanine (abbreviated ; adds
nucleic acids as drugs in complex biological systems flexibility to the polyamide chain to match the curvature
and the difficulty of demonstrating in situ occupancy of of DNA), and the substitution of the Py ring with hydroxy-
the target DNA binding site within the chromatin of live pyrrole (abbreviated Hp; discriminates TA from AT base
cells. Several groups have now unambiguously reported pairs), thus providing a specific polyamide pair to recog-
either in situ occupancy of DNA target sites by triplex- nize each of the 4 base pairs of double-stranded DNA
([25]; Table 1).forming oligonucleotides [9–12] or the capacity of tri-
plex-forming oligonucleotides to mediate site-specific The goal of this extensive and elegant series of studies
was to control the expression of a target gene with amutagenesis in eukaryotic cells [13, 14] and mice [15],
but no one has shown both site occupancy by triplex- small molecule [26]. To this end, several studies have
demonstrated that pyrrole-imidazole polyamides can lo-forming oligonucleotides and an effect on gene expres-
sion simultaneously in intact living mammalian cells. calize to the nucleus in cultured cells, and in some in-
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Like all good research, this paper raises a number ofTable 1. Minor Groove Recognition Code
interesting questions. A key issue for future endeavors
Base Pair Polyamide Pair will be elucidating the mechanism of inhibiting gene
GC Im/Py expression in cells. To this end, one must be mindful
CG Py/Im that cell treatments can have a multitude of effects, and
AT Py/Hp (Py/Py or /) separating the primary effects from the secondary ones
TA Hp/Py (Py/Py or /) can be challenging. It will be of particular interest to
Im, imidazole; Py, pyrrole; Hp, hydroxypyrrole; , -alanine. understand why some genes can be switched off by
polyamide treatment, while the expression of other
genes that also bear the polyamide binding site are
stances a measurable change in target gene expression
not affected. Is this a consequence of DNA structure,
provides indirect evidence of target site binding by the
occupancy of the binding site by transcription factors, or
small molecule [27–29]. Conversely, well-designed stud-
unstable polyamide binding in some actively transcribed
ies have been performed on nucleosomal binding by
genes? Ideally, DNA binding at the limited number of
polyamides, demonstrating that the nucleosome pre-
genes affected by polyamide treatment, such as HSP70,
sents a barrier to the binding of the polyamide in the
would be quantitatively demonstrated using LM-PCRminor groove of DNA only at specific contact points with
and compared to the occupancy of target sites in geneshistone proteins [30]. However, as with triplex-forming
that are not suppressed by the polyamide treatment.oligonucleotide “drugs,” direct demonstration of chro-
Several DNA interactive compounds have now been ap-matin binding in the nucleus of living cells and correla-
pended to minor groove binding polyamides; thesetion with suppression of gene expression by a site-spe-
agents include chlorambucil, used in this report, as wellcific or site-selective DNA binding agent has been an
as cyclopropapyrroloindole (CPI) [31], PBD, and camp-elusive goal until now. In the September issue of Chem-
tothecin [32]. It will be interesting to learn the gain inistry & Biology, Gottesfeld and coworkers provided the
biological activity afforded by these molecules com-first direct evidence for polyamide-DNA binding in the
pared to the already high-affinity polyamides. While wenuclear chromatin of living cells in culture [33]. The major
await further experiments with great interest, the studiesfindings of this paper are that a fluorescently labeled
described by Gottesfeld et al. represent an importantpolyamide is taken into the nucleus of four different
contribution to the field of designed site-selective DNAcells lines of lymphoid or myeloid lineage. The movie
binding agents, demonstrating that these agents canaccompanying this report (provided in the Supplemental
and do bind to their intended target sequences in livingData) graphically demonstrates the rapid uptake and
cells.nuclear localization of bodipy-labeled polyamide. The
polyamide in this paper is capable of targeting the hu-
man immunodeficiency virus-1 long terminal repeat
Scot W. Ebbinghaus(HIV-1 LTR) with a remarkable binding affinity of about
Arizona Cancer Center100 pM, but the target sequence is not unique to HIV-1;
1515 North Campbell Avenuethus, site-specific binding in the presence of total geno-
Tucson, Arizona 85724mic DNA may be reduced as a function of the number of
competing binding sites. The authors use a competitive
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biomedical applications. Nature has spent billions ofVaccine Delivery
years assembling nanoscale building blocks (such asby Carbon Nanotubes lipids, peptides, and nucleic acids) into complex and
functional structures. For example, selectivity and rec-
ognition at the molecular scale, such as antibody-anti-
gen interactions, is a critical feature of living systems.
Novel nanomaterials, such as carbon nanotubes, are However, nature has not had the opportunity to produce
under active investigation for potential use in biomedi- biomolecular interactions with the desired nanoscale
cal applications. In this issue of Chemistry & Biology, materials [7]. It has been shown that selective design
researchers describe antigen-antibody interactions and of peptides can be used to control interactions between
immune responses using peptide-carbon nanotube con- the biological and nonbiological world. Peptide se-
jugates. quences have been used to bind to metal particles [8]
and carbon nanotubes [4, 9, 10].
The interactions between carbon nanotubes and bio-The potential of novel nanomaterials, such as carbon
logical materials are mainly being investigated for bio-nanotubes, is enormous. These tubular arrangements
sensing (see [11, 12] and references therein). The basicof sp2 hybridized carbon atoms are under active investi-
concept for utilizing carbon nanotubes as transducersgation due to their phenomenal physical properties [1].
in biosensing applications is the ability to enable specificFor example, they can function as semiconductors in
interactions with the analyte through functionalizationnanoscale devices, be spun into the toughest material
of the nanotube surface and characterization of specific(man-made or natural [2]), or act as actuators with a
interactions (i.e., sensing) and reducing nonspecific in-force generation 100 times larger than that of mamma-
teractions.lian muscles.
In an important new development, the work by Bianco,Carbon nanotubes (CNT) exist in two types, single
Prato, and collaborators [13] published in this issuewall (SWNT) and multi wall (MWNT). SWNT have lengths
demonstrates the potential use of carbon nanotubes inof up to 10 m and diameter of up to 2 nm, depending
vaccine delivery. The basic concept for utilizing carbonon the production process. MWNT are thicker and
nanotubes in vaccine delivery is to link the antigen tolonger. CNT are not easily processed due to their lack
carbon nanotubes while retaining its conformation andof solubility in many solvents. However, the CNT carbon
thereby inducing antibody response with the right speci-atoms present an excellent platform for chemical func-
ficity. In addition, carbon nanotubes should not triggertionalization. Noncovalent and covalent functionaliza-
a response by the immune system, i.e., they should nottion has been utilized to overcome the problem of pro-
possess intrinsic immunogenicity.cessability (see [3–6] and references therein).
In previous work, the Bianco and Prato research group’sIn the last five years, inorganic nanomaterials such
carbon nanotubes were covalently functionalized withas nanocrystals, nanowires, and nanotubes have been
receiving an increasing amount of attention for potential a pyrrolidine ring through the 1,3-dipolar cycloaddition
